From his baronial boardroom in Pune, Adar Poonawalla can appear out upon the properly manicured turf of India’s most significant stud farm. About the several years, the family’s racehorses have gained the Indian Derby 10 situations. These times, nevertheless, the thoroughbreds gambolling throughout the paddock beneath his window may be the final issue on his intellect.
As the world gears up for a race to vaccinate billions of people towards Covid-19, the forty-year-old scion of India’s Poonawalla pharmaceuticals dynasty has emerged as a key participant. As chief executive of Serum Institute of India (SII), the world’s greatest vaccine manufacturer by quantity, Poonawalla’s manufacturing unit 70 miles exterior Mumbai has been operating at total tilt, scrambling to create 50m doses for every thirty day period of the AstraZeneca/University of Oxford vaccine which it is hoped will aid convey the killer virus under regulate.
Indicators of the pressures dealing with the organization